Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

Saborni Chakraborty(Stanford University), Taia T. Wang(Chan Zuckerberg Initiative (United States)), Paul J. Utz(Stanford University), Courtney Scallan(Stanford University), Elizabeth Mellins(Stanford University), Vamsee Mallajosyula(Stanford University), Mary Prahl(University of California, San Francisco), Steven T. Chen(Tisch Hospital), Mark M. Davis(Stanford Medicine), Fei Gao(Stanford University), Prasanna Jagannathan(Palo Alto University), Nimish Kathale(Stanford University), Kari C. Nadeau(Palo Alto University), Aanika Sinnott(J. Craig Venter Institute), Chaitan Khosla(Stanford University), Bali Pulendran(Palo Alto University), Prabhu S. Arunachalam(Stanford University), Xuhuai Ji(Stanford University), Marisa Holubar(Stanford University), Terri Gelbart(J. Craig Venter Institute), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Joseph C. González(Complejo Hospitalario Universitario de Santiago), Upinder Singh(University of Iowa), Scott D. Boyd(Stanford University), Bowie Yik-Ling Cheng(Stanford University), Holden T. Maecker(Stanford University), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Yarden Golan(Cornell University), Sacha Gnjatic(Tisch Hospital), Aruna Subramanian(Johns Hopkins University), Benjamín L. Sievers(University of Cambridge), Usama Ashraf(Stanford Medicine), Arianna G. Cassidy(University of California, San Francisco), Robert Sherwood(Cornell University), Gene S. Tan(J. Craig Venter Institute), Megha Dubey(Stanford University), Sheng Zhang(Nanchang University), Stephanie L. Gaw(University of California, San Francisco), Srijoni Chakraborty(San Jose State University), Kim Q.T. Tran(Stanford University), Yvonne Maldonado(Palo Alto University)
Science Translational Medicine
January 18, 2022
Cited by 137


Related Papers